ZYME Annual EBITDA
-$120.70 M
-$263.19 M-184.71%
31 December 2023
Summary:
As of January 23, 2025, ZYME annual earnings before interest, taxes, depreciation & amortization is -$120.70 million, with the most recent change of -$263.19 million (-184.71%) on December 31, 2023. During the last 3 years, it has risen by +$56.47 million (+31.87%). ZYME annual EBITDA is now -184.71% below its all-time high of $142.49 million, reached on December 31, 2022.ZYME EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZYME Quarterly EBITDA
-$31.59 M
-$8.50 M-36.81%
30 September 2024
Summary:
As of January 23, 2025, ZYME quarterly earnings before interest, taxes, depreciation & amortization is -$31.59 million, with the most recent change of -$8.50 million (-36.81%) on September 30, 2024. Over the past year, it has increased by +$3.90 million (+10.99%). ZYME quarterly EBITDA is now -109.82% below its all-time high of $321.66 million, reached on December 31, 2022.ZYME Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZYME TTM EBITDA
-$110.22 M
-$4.86 M-4.61%
30 September 2024
Summary:
As of January 23, 2025, ZYME TTM earnings before interest, taxes, depreciation & amortization is -$110.22 million, with the most recent change of -$4.86 million (-4.61%) on September 30, 2024. Over the past year, it has increased by +$21.64 million (+16.41%). ZYME TTM EBITDA is now -149.88% below its all-time high of $220.95 million, reached on September 30, 2023.ZYME TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZYME EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -184.7% | +11.0% | +16.4% |
| 3 y3 years | +31.9% | +45.7% | +45.3% |
| 5 y5 years | -305.9% | +0.9% | +23.0% |
ZYME EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -184.7% | +41.4% | -109.8% | +53.1% | -149.9% | +52.3% |
| 5 y | 5-year | -184.7% | +41.4% | -109.8% | +55.6% | -149.9% | +52.3% |
| alltime | all time | -184.7% | +41.4% | -109.8% | +55.6% | -149.9% | +52.3% |
Zymeworks EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$31.59 M(+36.8%) | -$110.22 M(+4.6%) |
| June 2024 | - | -$23.09 M(-34.9%) | -$105.36 M(-20.1%) |
| Mar 2024 | - | -$35.49 M(+77.0%) | -$131.87 M(+9.2%) |
| Dec 2023 | -$120.70 M(-184.7%) | -$20.05 M(-25.0%) | -$120.76 M(-154.7%) |
| Sept 2023 | - | -$26.73 M(-46.1%) | $220.95 M(+10.7%) |
| June 2023 | - | -$49.60 M(+103.4%) | $199.52 M(+7.6%) |
| Mar 2023 | - | -$24.38 M(-107.6%) | $185.46 M(+30.2%) |
| Dec 2022 | $142.49 M(-169.1%) | $321.66 M(-767.8%) | $142.49 M(-165.2%) |
| Sept 2022 | - | -$48.16 M(-24.3%) | -$218.62 M(-4.4%) |
| June 2022 | - | -$63.65 M(-5.5%) | -$228.66 M(-1.1%) |
| Mar 2022 | - | -$67.36 M(+70.8%) | -$231.13 M(+12.2%) |
| Dec 2021 | -$206.09 M(+16.3%) | -$39.45 M(-32.2%) | -$206.09 M(+2.2%) |
| Sept 2021 | - | -$58.20 M(-12.0%) | -$201.65 M(-6.0%) |
| June 2021 | - | -$66.13 M(+56.3%) | -$214.47 M(+15.0%) |
| Mar 2021 | - | -$42.31 M(+20.9%) | -$186.43 M(+5.2%) |
| Dec 2020 | -$177.17 M | -$35.01 M(-50.7%) | -$177.17 M(-16.9%) |
| Sept 2020 | - | -$71.02 M(+86.5%) | -$213.33 M(+22.5%) |
| June 2020 | - | -$38.08 M(+15.2%) | -$174.19 M(+6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$33.06 M(-53.5%) | -$163.18 M(+14.0%) |
| Dec 2019 | -$143.19 M(+381.6%) | -$71.16 M(+123.2%) | -$143.19 M(+137.0%) |
| Sept 2019 | - | -$31.88 M(+17.7%) | -$60.42 M(+31.2%) |
| June 2019 | - | -$27.08 M(+107.1%) | -$46.06 M(+107.0%) |
| Mar 2019 | - | -$13.07 M(-212.6%) | -$22.25 M(-25.1%) |
| Dec 2018 | -$29.73 M(+472.6%) | $11.61 M(-166.3%) | -$29.72 M(+398.6%) |
| Sept 2018 | - | -$17.52 M(+436.1%) | -$5.96 M(+52.2%) |
| June 2018 | - | -$3.27 M(-84.1%) | -$3.92 M(-63.1%) |
| Mar 2018 | - | -$20.54 M(-158.1%) | -$10.62 M(+104.6%) |
| Dec 2017 | -$5.19 M(-85.9%) | $35.37 M(-328.6%) | -$5.19 M(-89.8%) |
| Sept 2017 | - | -$15.47 M(+55.1%) | -$51.01 M(+8.0%) |
| June 2017 | - | -$9.98 M(-34.0%) | -$47.23 M(+7.3%) |
| Mar 2017 | - | -$15.11 M(+44.6%) | -$44.01 M(+19.2%) |
| Dec 2016 | -$36.91 M(+98.2%) | -$10.45 M(-10.6%) | -$36.91 M(+39.5%) |
| Sept 2016 | - | -$11.69 M(+73.1%) | -$26.46 M(+79.2%) |
| June 2016 | - | -$6.75 M(-15.7%) | -$14.77 M(+84.3%) |
| Mar 2016 | - | -$8.01 M | -$8.01 M |
| Dec 2015 | -$18.62 M(+48.7%) | - | - |
| Dec 2014 | -$12.52 M | - | - |
FAQ
- What is Zymeworks annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Zymeworks?
- What is Zymeworks annual EBITDA year-on-year change?
- What is Zymeworks quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Zymeworks?
- What is Zymeworks quarterly EBITDA year-on-year change?
- What is Zymeworks TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Zymeworks?
- What is Zymeworks TTM EBITDA year-on-year change?
What is Zymeworks annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ZYME is -$120.70 M
What is the all time high annual EBITDA for Zymeworks?
Zymeworks all-time high annual earnings before interest, taxes, depreciation & amortization is $142.49 M
What is Zymeworks annual EBITDA year-on-year change?
Over the past year, ZYME annual earnings before interest, taxes, depreciation & amortization has changed by -$263.19 M (-184.71%)
What is Zymeworks quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ZYME is -$31.59 M
What is the all time high quarterly EBITDA for Zymeworks?
Zymeworks all-time high quarterly earnings before interest, taxes, depreciation & amortization is $321.66 M
What is Zymeworks quarterly EBITDA year-on-year change?
Over the past year, ZYME quarterly earnings before interest, taxes, depreciation & amortization has changed by +$3.90 M (+10.99%)
What is Zymeworks TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ZYME is -$110.22 M
What is the all time high TTM EBITDA for Zymeworks?
Zymeworks all-time high TTM earnings before interest, taxes, depreciation & amortization is $220.95 M
What is Zymeworks TTM EBITDA year-on-year change?
Over the past year, ZYME TTM earnings before interest, taxes, depreciation & amortization has changed by +$21.64 M (+16.41%)